Stratos Wealth Partners, Ltd. Catalent, Inc. Transaction History

Stratos Wealth Partners, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$29.95 - $46.34 $4,252 - $6,580	-142 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$40.12 - $45.55 $5,697 - $6,468	142 New	142 $6,000
Q2 2018 Aug 13, 2018	SELL	$38.72 - $42.52 $13,242 - $14,541	-342 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$39.4 - $47.39 $7,880 - $9,478	200 Added 140.85%	342 $14,000
Q4 2017 Feb 09, 2018	BUY	$37.27 - $43.02 $5,292 - $6,108	142	142 $6,000

16.5M

10.7K

4.5K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.